Effect of warfarin nonadherence on control of the International Normalized Ratio

被引:74
作者
Waterman, AD
Milligan, PE
Bayer, L
Banet, GA
Gatchel, SK
Gage, BF
机构
[1] Washington Univ, Sch Med, Div Gen Med Sci, St Louis, MO 63110 USA
[2] Comprehens Neuropsychol Serv, Cheshire, CT USA
[3] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO 63110 USA
关键词
age; anticoagulants; compliance; geriatrics; International Normalized Ratio; patients; warfarin;
D O I
10.1093/ajhp/61.12.1258
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective. The frequency and causes of aberrant International Normalized Ratios (INRs) in warfarin recipients and the percentage explainable by warfarin nonadherence were studied. Methods. The medical records of patients whose warfarin therapy was monitored by a telephone-based anticoagulation service in a Midwestern urban hospital between March 2000 and March 2001 were reviewed for causes of out-of-range INRs, the percentage of out-of-range INRs attributable to warfarin nonadherence, and demographic and clinical variables predictive of nonadherence. Results. Data from 347 patients were studied. The cohort yielded 4305 INRs, of which 1002 (23%) were out of range (lower than 1.8 or higher than 3.4). Thirty-six percent of the out-of-range INRs were due to warfarin or dietary nonadherence, 9% were due to medical systems problems (including drug interactions), 18% were due to a change in clinical status, and 38% were idiopathic. Age younger than 65 years, age greater than 80 years, and living closer to the laboratory were predictive of warfarin nonadherence. Conclusion. Warfarin nonadherence was the most common cause of explainable aberrant INRs in patients taking warfarin. Age younger than 65 years, age greater than 80 years, and living close to the laboratory were predictive of warfarin nonadherence.
引用
收藏
页码:1258 / 1264
页数:7
相关论文
共 51 条
  • [31] KOUDSTAAL PJ, 1995, NEW ENGL J MED, V333, P5
  • [32] The effect of self-monitoring the INR on quality of anticoagulation and quality of life
    Kulinna, W
    Ney, D
    Wenzel, T
    Heene, DL
    Harenberg, J
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 (01) : 123 - 126
  • [33] APPARENT WARFARIN RESISTANCE DUE TO POOR COMPLIANCE
    KUMAR, S
    HAIGH, JRM
    DAVIES, JA
    ROBERTS, BE
    FEELY, MP
    [J]. CLINICAL AND LABORATORY HAEMATOLOGY, 1989, 11 (02): : 161 - 163
  • [34] KUMAR S, 1989, THROMB HAEMOSTASIS, V62, P729
  • [35] Liu HH, 2001, ANN INTERN MED, V134, P968, DOI 10.7326/0003-4819-134-10-200105150-00011
  • [36] Compliance with antihypertensive therapy among elderly Medicaid enrollees: The roles of age, gender, and race
    Monane, M
    Boh, RL
    Gurwitz, JH
    Glynn, RJ
    Levin, R
    Avorn, J
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1996, 86 (12) : 1805 - 1808
  • [37] The effects of initial drug choice and comorbidity on antihypertensive therapy compliance - Results from a population-based study in the elderly
    Monane, M
    Bohn, RL
    Gurwitz, JH
    Glynn, RJ
    Levin, R
    Avorn, J
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (07) : 697 - 704
  • [38] Relationship of distance from a radiotherapy facility and initial breast cancer treatment
    Nattinger, AB
    Kneusel, RT
    Hoffmann, RG
    Gilligan, MA
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (17) : 1344 - 1346
  • [39] Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)
    Palareti, G
    Leali, N
    Coccheri, S
    Poggi, M
    Manotti, C
    DAngelo, A
    Pengo, V
    Erba, N
    Moia, M
    Ciavarella, N
    Devote, G
    Berrettini, M
    Musolesi, S
    [J]. LANCET, 1996, 348 (9025) : 423 - 428
  • [40] PETERSEN P, 1989, LANCET, V1, P175